LivingGLP1
Study S000408

The Effect of Weekly Semaglutide Treatment on Energy Expenditure

ClinicalTrials.gov record

Registration

Registration
NCT06390501
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Status
COMPLETED
Enrollment
60
Start
2024-04-01
Primary completion
2025-08-15
Lead sponsor
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Conditions
Obesity; Drug
Interventions
DRUG:Semaglutide; DRUG:Placebo
Results posted
FALSE

Registered primary outcomes

  • Changes of Total Energy Expenditure Assessed by Doubly Labeled Water Analysis [From baseline at week 0 to week 24]
  • Changes of Energy Expenditure Assessed by Chamber [From baseline at week 0 to week 24]
  • Changes of Resting Energy Expenditure [From baseline at week 0 to week 24]
  • Changes of Physical Activity [From baseline at week 0 to week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.